Search

everythinglearnresearchcommunity

for

Search:↓

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

AS101 reduces hair loss from chemotherapy.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

A young girl developed serious bone inflammation in her skull after a skin graft, which is a rare but severe condition.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Cancer treatments often cause skin, nail, and hair problems.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Patients prefer non-drug methods like massage and music to manage chemotherapy side effects, but standardization is needed.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.